Basit öğe kaydını göster

Propylthiouracil-Induced Thrombotic Leukocytoclastic Vasculitis

dc.contributor.authorGÜL, Nurdan
dc.contributor.authorAlagol, Faruk
dc.contributor.authorYarman, Sema
dc.contributor.authorTanakol, Refik
dc.contributor.authorKutluturk, Faruk
dc.date.accessioned2021-03-03T18:49:49Z
dc.date.available2021-03-03T18:49:49Z
dc.date.issued2006
dc.identifier.citationKutluturk F., GÜL N., Yarman S., Tanakol R., Alagol F., "Propylthiouracil-Induced Thrombotic Leukocytoclastic Vasculitis", TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, cilt.10, sa.2, ss.45-47, 2006
dc.identifier.issn1301-2193
dc.identifier.othervv_1032021
dc.identifier.otherav_513a637b-a5ac-4405-8138-017de764f233
dc.identifier.urihttp://hdl.handle.net/20.500.12627/57766
dc.description.abstractAntithyroid drug therapy with Propylthiouracil (PTU) is commonly used in Graves' disease. One of the most serious complications of this drug is PTU-induced leukocytoclastic vasculitis. We report a 23 year-old woman who developed leukocytoclastic vasculitis which is a rare and serious side effect during PTU therapy for Graves' disease. The observation of cutaneous vasculitis in this patient during administration of PTU indicates that reguler follow-up of patients on antithyroid drug regimen is mandatory.
dc.language.isoeng
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.subjectTıp
dc.titlePropylthiouracil-Induced Thrombotic Leukocytoclastic Vasculitis
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume10
dc.identifier.issue2
dc.identifier.startpage45
dc.identifier.endpage47
dc.contributor.firstauthorID2274483


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster